Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
about
Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis of More Than 20 000 Patients.Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway
P2860
Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy and Safety of Bevaciz ...... atic Review and Meta-Analysis.
@en
type
label
Efficacy and Safety of Bevaciz ...... atic Review and Meta-Analysis.
@en
prefLabel
Efficacy and Safety of Bevaciz ...... atic Review and Meta-Analysis.
@en
P2093
P50
P1476
Efficacy and Safety of Bevaciz ...... atic Review and Meta-Analysis.
@en
P2093
Carmine Pinto
Fausto Petrelli
Gianluca Masi
Giuseppe Aprile
Luca Porcu
Mario Scartozzi
Sandro Barni
P304
P356
10.1016/J.CLCC.2016.08.006
P407
P577
2016-08-31T00:00:00Z